
Study yields new data on Mpox vaccine effectiveness
A study under the leadership of Prof. Leif Erik Sander has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. The results of the study have now been published in The Lancet Infectious Diseases.